Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT04754672

Aerobic Fitness or Muscle Mass Training to Improve Colorectal Cancer Outcome

Led by Radboud University Medical Center · Updated on 2023-11-18

228

Participants Needed

13

Research Sites

300 weeks

Total Duration

On this page

Sponsors

R

Radboud University Medical Center

Lead Sponsor

U

UMC Utrecht

Collaborating Sponsor

AI-Summary

What this Trial Is About

Evidence from randomized controlled trials shows that exercise during cancer treatment benefits physical fitness, fatigue and quality of life. Since the effect of exercise on clinical outcome is currently unknown, exercise is not included as integral part of standard cancer care. Moreover, evidence regarding the optimal exercise prescription in terms of type and dose is lacking. To maintain quality of life in patients receiving palliative treatment with chemotherapy, toxicity-induced modifications in the prescribed chemotherapy dose are common. Such modifications - occurring in 40% of patients with metastatic colorectal cancer - may reduce benefit of treatment. The investigators hypothesize that exercise prevents chemotherapy dose modifications by reducing toxicity and enhancing psychological strength. Additionally, based on studies in rodents and preliminary data in patients with cancer, the researchers hypothesize that exercise has beneficial effects on the functionality of the natural killer cells, which play an important role in the innate immune defense against cancer. Both, fewer dose modifications and improved immune function may improve progression-free survival. This study is a three-armed trial comparing resistance exercise, aerobic interval exercise and usual care in patients with metastatic colorectal cancer to select the optimal exercise prescription for preventing chemotherapy dose modifications. The trial will use a Bayesian adaptive multi-arm multi-stage design with several interim analyses after which an ineffective study arm can be dropped early. This novel design makes the trial more efficient and reduces patients' exposure to suboptimal study arms. Evidence regarding the exercise effects on i) clinical outcome, ii) the optimal exercise prescription, and iii) the underlying mechanisms, elucidates the potential of exercise to boost benefit from chemotherapy treatment. This evidence provides leads to improve progression-free survival and quality of life of patients suffering from one of the leading causes of cancer death worldwide.

CONDITIONS

Official Title

Aerobic Fitness or Muscle Mass Training to Improve Colorectal Cancer Outcome

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with metastatic colorectal cancer requiring palliative chemotherapy
  • Scheduled for first-line doublet or triplet chemotherapy according to national guidelines
  • Able and willing to provide written informed consent
Not Eligible

You will not qualify if you...

  • Life expectancy less than 6 months
  • Unable to perform basic daily activities such as walking or biking
  • Presence of cognitive disorders or severe emotional instability (e.g., schizophrenia, Alzheimer’s, alcohol addiction)
  • Other disabling conditions affecting exercise ability (e.g., severe heart failure, severe COPD, orthopedic or neurological disorders)
  • Insufficient mastery of the Dutch language
  • Serious cardiovascular or cardiopulmonary conditions risking exercise safety
  • Already participating in structured vigorous aerobic or resistance exercise two or more times per week similar to the intervention

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 13 locations

1

Jeroen Bosch Ziekenhuis

's-Hertogenbosch, Netherlands, 5223 GZ

Actively Recruiting

2

Flevoziekenhuis

Almere Stad, Netherlands, 1315 RA

Actively Recruiting

3

Meander Medisch Centrum

Amersfoort, Netherlands, 3813TZ

Actively Recruiting

4

Ziekenhuis Amstelland

Amstelveen, Netherlands, 1186AM

Actively Recruiting

5

Amsterdam UMC

Amsterdam, Netherlands, 1007MB

Actively Recruiting

6

Netherlands Cancer Institute

Amsterdam, Netherlands

Actively Recruiting

7

Rijnstate Ziekenhuis

Arnhem, Netherlands, 6815 AD

Actively Recruiting

8

Ziekenhuis Amphia

Breda, Netherlands, 4818CK

Actively Recruiting

9

Catharina Ziekenhuis

Eindhoven, Netherlands, 5623 EJ

Actively Recruiting

10

Spaarne Gasthuis

Hoofddorp, Netherlands, 2134TM

Actively Recruiting

11

Radboudumc

Nijmegen, Netherlands, 6525GA

Actively Recruiting

12

Canisius Wilhelmina Ziekenhuis

Nijmegen, Netherlands, 6532SZ

Actively Recruiting

13

UMCU

Utrecht, Netherlands, 3508GA

Actively Recruiting

Loading map...

Research Team

L

Laurien M Buffart, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here